The taboo of the Albendazole

This product disables the following:

1. Postmenopausal women;

2. Pregnant or lactating women;

3. Patients with severe renal impairment (creatinine clearance rate <20ml/min);

4. Patients with moderate to severe liver damage;

5. The patient is known to be highly sensitive to albendazole and its preparation excipients.